Wilbanks Smith Thomas Asset Management buys $4,714,822 stake in Procter & Gamble Co (PG)

Procter & Gamble Co (PG) : Wilbanks Smith Thomas Asset Management scooped up 78 additional shares in Procter & Gamble Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 25, 2016. The investment management firm now holds a total of 58,847 shares of Procter & Gamble Co which is valued at $4,714,822.Procter & Gamble Co makes up approximately 0.56% of Wilbanks Smith Thomas Asset Management’s portfolio.

Procter & Gamble Co opened for trading at $80.02 and hit $81.3 on the upside on Monday, eventually ending the session at $80.97, with a gain of 1.06% or 0.85 points. The heightened volatility saw the trading volume jump to 78,62,625 shares. Company has a market cap of $215,530 M.

Other Hedge Funds, Including , Punch Associates Investment Management reduced its stake in PG by selling 2,631 shares or 5.0% in the most recent quarter. The Hedge Fund company now holds 49,987 shares of PG which is valued at $4,004,958. Procter & Gamble Co makes up approx 0.48% of Punch Associates Investment Management’s portfolio. Strs Ohio sold out all of its stake in PG during the most recent quarter. The investment firm sold 3,130,320 shares of PG which is valued $253,399,404.Private Trust Co Na boosted its stake in PG in the latest quarter, The investment management firm added 4,697 additional shares and now holds a total of 65,272 shares of Procter & Gamble Co which is valued at $5,283,768. Procter & Gamble Co makes up approx 1.41% of Private Trust Co Na’s portfolio.Horizon Kinetics reduced its stake in PG by selling 65 shares or 0.82% in the most recent quarter. The Hedge Fund company now holds 7,829 shares of PG which is valued at $644,327. Procter & Gamble Co makes up approx 0.02% of Horizon Kinetics’s portfolio.

On the company’s financial health, Procter & Gamble Co reported $0.86 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.82. The company had revenue of $15755.00 million for the quarter, compared to analysts expectations of $15809.32 million. The company’s revenue was down -6.9 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.92 EPS.

Many Wall Street Analysts have commented on Procter & Gamble Co. Shares were Reiterated by UBS on Apr 27, 2016 to “Neutral” and Lowered the Price Target to $ 85 from a previous price target of $88 .Shares were Reiterated by B. Riley & Co. on Mar 30, 2016 to “Neutral” and Lowered the Price Target to $ 74 from a previous price target of $81 .Procter & Gamble Co was Upgraded by Sterne Agee CRT to ” Buy” on Feb 16, 2016.

The Procter & Gamble Company (P&G) provides consumer packaged goods. The Company operates in five segments under GBUs: Beauty which offers a range of products ranging from deodorants to cosmetics to skin care; Grooming which includes blades razors and electronic hair removal devices such as electric razors and epilators; Health Care which includes oral care and personal health care products.; Fabric Care and Home Care which consists of a range of fabric care products home care products and batteries and Baby Feminine and Family Care which offers diapers pants baby wipe Bounty paper towel and Charmin toilet paper brands. The Company’s products are sold in over 180 countries and territories. P&G’s customers include mass merchandisers grocery stores membership club stores drug stores department stores salons distributors e-commerce and stores.

Leave a Reply

Procter & Gamble Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Procter & Gamble Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.